Vladimir Wolf
Keine laufenden Positionen mehr
Karriereverlauf von Vladimir Wolf
Ehemalige bekannte Positionen von Vladimir Wolf
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
MultiplexDX Inc.
 MultiplexDX Inc. Medical SpecialtiesHealth Technology MultiplexDX sro develops personalized cancer diagnostic tests. It offers RNA sequencing, barcoded pre-adenylated 3-adapters, small RNA library preparation kit, fluorescent in situ hybridization, FullRNAlook, multi-labeled fish probes and fish core services. The company was founded by Pavol Cekan and Vladimir Wolf in 2016 and is headquartered in Presov, Slovakia. | Gründer | 01.01.2016 | - |
Trophogen, Inc.
 Trophogen, Inc. BiotechnologyHealth Technology Trophogen, Inc. develops glycoprotein hormones and therapeutic applications. The firm's research is focused on developing super-agonists and antagonists of cystine knot growth factors and therapy and imaging of thyroid, ovarian, breast, prostate and testicular cancers. The company was founded by Bruce D. Weintraub and Mariusz W. Szkudlinski in July 2001 and is headquartered in Rockville, MD. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 | - |
| Corporate Officer/Principal | 01.01.2004 | - |
Ausbildung von Vladimir Wolf
| University of Bern | Doctorate Degree |
| Julius-Maximilians-Universität Würzburg | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 3 |
| Schweiz | 2 |
| Deutschland | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Trophogen, Inc.
Trophogen, Inc. BiotechnologyHealth Technology Trophogen, Inc. develops glycoprotein hormones and therapeutic applications. The firm's research is focused on developing super-agonists and antagonists of cystine knot growth factors and therapy and imaging of thyroid, ovarian, breast, prostate and testicular cancers. The company was founded by Bruce D. Weintraub and Mariusz W. Szkudlinski in July 2001 and is headquartered in Rockville, MD. | Health Technology |
MultiplexDX Inc.
MultiplexDX Inc. Medical SpecialtiesHealth Technology MultiplexDX sro develops personalized cancer diagnostic tests. It offers RNA sequencing, barcoded pre-adenylated 3-adapters, small RNA library preparation kit, fluorescent in situ hybridization, FullRNAlook, multi-labeled fish probes and fish core services. The company was founded by Pavol Cekan and Vladimir Wolf in 2016 and is headquartered in Presov, Slovakia. | Health Technology |
- Börse
- Insiders
- Vladimir Wolf
- Erfahrung
